{
    "nctId": "NCT03713255",
    "briefTitle": "Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial",
    "officialTitle": "Analgesic Benefits of the Novel Mid-point Transverse Process to Pleura (MTP) Block for Ambulatory Breast Cancer Surgery: A Randomized Controlled Trial",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Acute Pain, Anesthesia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Postoperative analgesia during the first 24 hours.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* English or French Speaking\n* Scheduled for major breast surgery\n* ASA physical status classification I-III\n* BMI \\<30kg/m2\n\nExclusion Criteria:\n\n* Prior ipsilateral breast surgery\n* Pre-existing neurological deficit or peripheral neuropathy involving the ipsilateral chest\n* Contraindications to regional anesthesia\n* Patient refusal of regional technique\n* Chronic pain disorder\n* Chronic opioid use\n* Inability to provide informed consent",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}